VIBRANT (NCT06164704) was a Phase 2 global, randomized, double-blind, placebo-controlled, parallel group clinical trial that evaluated the efficacy and safety of verekitug over 24 weeks in 81 adults ...

Vaults and Vault Doors Market Projected to Reach $1,484.14 Million by 2033, Growing at 7% CAGR ...